BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 27050863)

  • 1. Site-Specific Albumination as an Alternative to PEGylation for the Enhanced Serum Half-Life in Vivo.
    Yang B; Lim SI; Kim JC; Tae G; Kwon I
    Biomacromolecules; 2016 May; 17(5):1811-7. PubMed ID: 27050863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Site-specific albumination of a therapeutic protein with multi-subunit to prolong activity in vivo.
    Lim SI; Hahn YS; Kwon I
    J Control Release; 2015 Jun; 207():93-100. PubMed ID: 25862515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azidoethoxyphenylalanine as a Vibrational Reporter and Click Chemistry Partner in Proteins.
    Tookmanian EM; Phillips-Piro CM; Fenlon EE; Brewer SH
    Chemistry; 2015 Dec; 21(52):19096-103. PubMed ID: 26608683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-Assembly of Temperature-Responsive Protein-Polymer Bioconjugates.
    Moatsou D; Li J; Ranji A; Pitto-Barry A; Ntai I; Jewett MC; O'Reilly RK
    Bioconjug Chem; 2015 Sep; 26(9):1890-9. PubMed ID: 26083370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and spectrophotometric investigation of two unnatural amino-acid altered chromophores in the superfolder green fluorescent protein.
    Olenginski GM; Piacentini J; Harris DR; Runko NA; Papoutsis BM; Alter JR; Hess KR; Brewer SH; Phillips-Piro CM
    Acta Crystallogr D Struct Biol; 2021 Aug; 77(Pt 8):1010-1018. PubMed ID: 34342274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functionalisation of brush polyethylene glycol polymers with specific lipids extends their elimination half-life through association with natural lipid trafficking pathways.
    Abdallah M; Lin L; Styles IK; Mörsdorf A; Grace JL; Gracia G; Nowell C; Quinn JF; Landersdorfer CB; Whittaker MR; Trevaskis NL
    Acta Biomater; 2024 Jan; 174():191-205. PubMed ID: 38086497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulating Chemokine-Receptor Interactions through the Site-Specific Bioorthogonal Conjugation of Photoresponsive DNA Strands.
    van Stevendaal MHME; Hazegh Nikroo A; Mason AF; Jansen J; Yewdall NA; van Hest JCM
    Bioconjug Chem; 2023 Nov; 34(11):2089-2095. PubMed ID: 37856672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of therapeutic protein variants with the human serum albumin binding capacity via site-specific fatty acid conjugation.
    Cho J; Lim SI; Yang BS; Hahn YS; Kwon I
    Sci Rep; 2017 Dec; 7(1):18041. PubMed ID: 29269881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AlbuCatcher for Long-Acting Therapeutics.
    Rho JH; Lee JH; Kwon I
    ACS Omega; 2024 May; 9(21):22990-23000. PubMed ID: 38826564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unraveling Complex Local Protein Environments with 4-Cyano-l-phenylalanine.
    Lee B; Papoutsis BM; Wong NY; Piacentini J; Kearney C; Huggins NA; Cruz N; Ng TT; Hao KH; Kramer JS; Fenlon EE; Nerenberg PS; Phillips-Piro CM; Brewer SH
    J Phys Chem B; 2022 Nov; 126(44):8957-8969. PubMed ID: 36317866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probing the effectiveness of spectroscopic reporter unnatural amino acids: a structural study.
    Dippel AB; Olenginski GM; Maurici N; Liskov MT; Brewer SH; Phillips-Piro CM
    Acta Crystallogr D Struct Biol; 2016 Jan; 72(Pt 1):121-30. PubMed ID: 26894540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HSA-ZW800-PEG for Enhanced Optophysical Stability and Tumor Targeting.
    Jang P; Ser J; Cardenas K; Kim HJ; Hickey M; Jang J; Gladstone J; Bailey A; Dinh J; Nguyen V; DeMarco E; Srinivas S; Kang H; Kashiwagi S; Bao K; Yamashita A; Choi HS
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of Multivalent Conjugates with a Single Non-Canonical Amino Acid.
    Burrow NK; Gourdie RK; King EA; Travis CR; Goff CM; Nimmo ZM; Berg JM; Boyt EL; Young DD
    Chembiochem; 2023 Dec; 24(23):e202300565. PubMed ID: 37737964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of orthogonal aminoacyl-tRNA synthetase mutant for incorporating a non-canonical amino acid.
    Lee D; Kim JG; Kim TW; Choi JI
    AMB Express; 2024 May; 14(1):60. PubMed ID: 38782816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced therapeutic potential of antibody fragment via IEDDA-mediated site-specific albumin conjugation.
    Go EB; Lee JH; Cho JH; Kwon NH; Choi JI; Kwon I
    J Biol Eng; 2024 Apr; 18(1):23. PubMed ID: 38576037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Protein-Based, Long-Acting HIV-1 Fusion Inhibitor with an Improved Pharmacokinetic Profile.
    Xu W; Cong Z; Duan Q; Wang Q; Su S; Wang R; Lu L; Xue J; Jiang S
    Pharmaceuticals (Basel); 2022 Mar; 15(4):. PubMed ID: 35455421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical Modification of Cysteine with 3-Arylpropriolonitrile Improves the In Vivo Stability of Albumin-Conjugated Urate Oxidase Therapeutic Protein.
    Yang B; Kwon I
    Biomedicines; 2021 Sep; 9(10):. PubMed ID: 34680451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thermostable and Long-Circulating Albumin-Conjugated
    Yang B; Kwon I
    Pharmaceutics; 2021 Aug; 13(8):. PubMed ID: 34452259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Minimal Effect of Linker Length for Fatty Acid Conjugation to a Small Protein on the Serum Half-Life Extension.
    Cho J; Park J; Tae G; Jin MS; Kwon I
    Biomedicines; 2020 Apr; 8(5):. PubMed ID: 32357510
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.